Search results for "Primary"

showing 10 items of 2384 documents

HPV infection in relation to OSCC histological grading and TNM stage. Evalutation by traditional statistics and fuzzy logic model

2006

We aimed to evaluate if in oral squamous cell carcinoma (OSCC) there is a relationship between histological grading (HG), TNM clinical stage and HPV infection; and to study the performance of fuzzy logic compared to traditional statistics, in the analysis of HPV status and correlates of OSCC. In cross-sectional analysis, the study group comprised 63 patients (mean age 68.89 years (SD ± 11.78), range (32–93); males 28 (44.4%), females 35 (55.6%)) with OSCC histologically diagnosed. HPV-DNA was studied in exfoliated oral epithelial cells by nested PCR (MY09/MY11 and GP5+/GP6+ primers). Data were analysed in parallel by traditional statistics with multivariate analysis and a fuzzy logic (FL) t…

AdultMaleCancer ResearchMultivariate analysisStage iiBiologyModels BiologicalFuzzy LogicStatisticsCarcinomamedicineHumansGrading (tumors)AgedAged 80 and overOSCC HPV-DNA GradingPapillomavirus InfectionsHPV infectionMiddle Agedmedicine.diseasestomatognathic diseasesCross-Sectional StudiesIncreased riskOncologyMultivariate AnalysisCarcinoma Squamous CellFemaleMouth NeoplasmsPrimary tumour sizeOral SurgeryStage iv
researchProduct

Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.

2006

We reviewed a large series of patients with essential thrombocythemia diagnosed on the basis of the Polycythemia Vera Study Group criteria, and reclassified them by evaluating their major morphologic features and clinical course using the World Health Organization classification. The morphologic review of the bone marrow biopsies of 116 patients (44 males and 72 females; aged 19 - 83 years, median 55 years; median follow-up 121 months) led to 22 cases (19%) being classified as essential thrombocythemia (ET), 24 (21%) as chronic idiopathic myelofibrosis (CIMF)-0, 44 (37%) as CIMF-1, 13 (12%) as CIMF-2, 9 (8%) as latent phase polycythemia vera, and four (3%) as chronic myeloproliferative diso…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyIdiopathic myelofibrosisSingle CenterWorld healthDiagnosis DifferentialPolycythemia veraBone Marrowhemic and lymphatic diseasesmedicineHumansPolycythemia VeraAgedAged 80 and overEssential thrombocythemiabusiness.industryHistologyBone Marrow ExaminationHematologyMiddle Agedmedicine.diseaseHaematopoiesismedicine.anatomical_structureOncologyPrimary MyelofibrosisChronic DiseaseFemaleBone marrowbusinessGranulocytesThrombocythemia EssentialLeukemialymphoma
researchProduct

Cytogenetic findings in secondary acute nonlymphocytic leukemia

1992

Abstract We here report the results of cytogenetic studies carried out in eight patients with acute nonlymphocytic leukemia developed after primary neoplasias. In seven of the reported cases, clonal chromosome aberrations were found, some being specific of de novo acute nonlymphocytic leukemia (ANLL). Numerical abnormalities were detected, such as the total monosomy of chromosomes 5, 7, 21, trisomy of chromosomes 8, 11, 15, and duplication of chromosome Y. Structural changes were also observed: a del(12)(p12), a del(16)(q22), the translocations t(3;5)(p21;q35),t(3;7)(p21;q35), and t(12;14)(p12;q32) and other changes involving chromosome 8. The finding of a hypertetraploid karyotype with com…

AdultMaleCancer Researchmedicine.medical_specialtyMonosomyChromosomal translocationBiologyTranslocation GeneticPolyploidyMonosomyhemic and lymphatic diseasesGeneticsmedicineHumansMolecular BiologyAgedChromosome AberrationsCytogeneticsChromosomeNeoplasms Second PrimaryKaryotypeMiddle Agedmedicine.diseaseLymphomaLeukemia Myeloid AcuteLeukemiaImmunologyCancer researchChromosomes Human Pair 5FemaleTrisomyChromosomes Human Pair 7Cancer Genetics and Cytogenetics
researchProduct

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multic…

2006

BACKGROUND. To date, the standard treatment for patients who have carcinoma of unknown primary site has not been established. METHODS. In this randomized Phase II study, 66 previously untreated patients (33 patients per arm) with carcinomas of unknown primary site received cisplatin (35 mg/m2) and gemcitabine (1000 mg/m2) with either paclitaxel (70 mg/m2) or vinorelbine (25 mg/m2), and all drugs were administered intravenously on Days 1 and 8 of a 21-day cycle. Twenty-nine patients (44%) presented with ≥2 involved sites. The pathologic diagnosis was mainly adenocarcinoma (48 patients; 72.7%) and squamous carcinoma (7 patients; 10.6%). RESULTS. In the first arm, 16 patients (48.5%) experienc…

AdultMaleCancer Researchmedicine.medical_specialtyPaclitaxelmedicine.medical_treatmentPhases of clinical researchVinorelbineVinblastineGastroenterologyDeoxycytidineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAgedChemotherapybusiness.industryStandard treatmentCarcinomaVinorelbineMiddle AgedGemcitabineGemcitabineSquamous carcinomaSurgeryRegimenOncologyTolerabilityItalyInjections IntravenousNeoplasms Unknown PrimaryFemaleCisplatinbusinessmedicine.drugCancer
researchProduct

Cancer causes and prevention: a condensed appraisal in Europe in 2008.

2008

The rising cancer burden in Europe, mainly due to a rapidly ageing population, demands a clear and coordinated response from researchers, oncologists and other physicians, public health professionals and policy-makers. Primary and secondary prevention is the front line in the complex battle against cancer in Europe. To formulate the best strategies in this fight, the major determinants of cancer are summarised in the order of their relative importance in Europe, including tobacco smoking, alcohol, diet, physical activity, occupational factors, environmental factors, infectious agents and genetic and hormonal factors. Furthermore, this paper offers explicit recommendations on individual beha…

AdultMaleCancer Researchmedicine.medical_specialtyPopulation ageingAlcohol DrinkingPublic policySmoking PreventionSDG 3 - Good Health and Well-beingEnvironmental healthNeoplasmsmedicineHumansMortalityEpidemiologic FactorsExerciseLife StyleCancer preventionbusiness.industryPublic healthSmokingCancerFront lineEnvironmental exposureEnvironmental ExposureMiddle AgedOverweightmedicine.diseaseDietEuropePrimary PreventionOncologyImmune System DiseasesFemalebusinessEuropean journal of cancer (Oxford, England : 1990)
researchProduct

Increased facilitation of the primary motor cortex following 1 Hz repetitive transcranial magnetic stimulation of the contralateral cerebellum in nor…

2005

Connections between the cerebellum and the contralateral motor cortex are dense and important, but their physiological significance is difficult to measure in humans. We have studied a group of 10 healthy subjects to test whether a modulation of the excitability of the left cerebellum can affect the excitability of the contralateral motor cortex. We used repetitive transcranial magnetic stimulation (rTMS) at 1 Hz frequency to transiently depress the excitability of the left cerebellar cortex and paired-pulse TMS testing of intracortical inhibition (ICI) and intracortical facilitation (ICF) to probe the excitability of cortico-cortical connections in the right motor cortex. The cortical sile…

AdultMaleCerebellumTMS Cerebellum Motor cortex Motor evoked potentialsmedicine.medical_treatmentbehavioral disciplines and activitiesSynaptic TransmissionMotor evoked potentialsFunctional LateralityNOCerebellar CortexPurkinje CellsCerebellum; Motor cortex; Motor evoked potentials; TMS;Reference ValuesCerebellumNeural PathwaysmedicineReaction TimeHumansEvoked PotentialsSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicamusculoskeletal neural and ocular physiologyGeneral NeuroscienceInterstimulus intervalMotor CortexNeural InhibitionEvoked Potentials MotorTranscranial Magnetic StimulationElectric StimulationTranscranial magnetic stimulationElectrophysiologyReference Values; Humans; Cerebellum; Neural Inhibition; Electric Stimulation; Cerebellar Cortex; Purkinje Cells; Motor Cortex; Evoked Potentials Motor; Adult; Neural Pathways; Transcranial Magnetic Stimulation; Synaptic Transmission; Female; Functional Laterality; Male; Reaction Time; Cerebellar Nucleimedicine.anatomical_structurenervous systemMotorCerebellar NucleiTMSCerebellar cortexSilent periodSettore MED/26 - NeurologiaFemalePrimary motor cortexPsychologyNeurosciencepsychological phenomena and processesMotor cortexNeuroscience letters
researchProduct

Predictive Scores in Primary Biliary Cirrhosis

2015

GOALS The aim of this study was to assess the long-term outcome of primary biliary cirrhosis (PBC) patients and to test the clinical value of various outcome models, such as the Mayo Risk Score (MRS), in a large single-center cohort in Germany. BACKGROUND PBC is a chronic autoimmune liver disease with a female gender predominance and a peak incidence in the fifth decade of life. PBC is characterized by portal inflammation and immune-mediated destruction of intrahepatic bile ducts in liver histology and the presence of antimitochondrial antibodies in the serum of nearly 95% of patients. In 5% to 20% of patients an overlap syndrome with autoimmune hepatitis (AIH) is diagnosed. Ursodeoxycholic…

AdultMaleCholagogues and Cholereticsmedicine.medical_specialtyPathologyAdolescentmedicine.medical_treatmentIntrahepatic bile ductsAutoimmune hepatitisLiver transplantationSeverity of Illness IndexGastroenterologyYoung AdultLiver diseasePrimary biliary cirrhosisPredictive Value of TestsInternal medicinemedicineHumansAspartate AminotransferasesChildAgedRetrospective StudiesAged 80 and overFramingham Risk ScoreLiver Cirrhosis BiliaryPlatelet Countbusiness.industryUrsodeoxycholic AcidGastroenterologyBilirubinOverlap syndromeMiddle AgedAlkaline PhosphatasePrognosismedicine.diseasedigestive system diseasesUrsodeoxycholic acidLiver TransplantationHepatitis AutoimmuneImmunoglobulin MImmunoglobulin GFemalebusinessFollow-Up Studiesmedicine.drugJournal of Clinical Gastroenterology
researchProduct

Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series

1999

No established medical therapy alters the progressive course of primary sclerosing cholangitis.To explore the potential usefulness of combined therapy with azathioprine, steroids and ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis.Case series.University hospital in Mainz, Germany.15 patients with primary sclerosing cholangitis.Azathioprine (1 to 1.5 mg/kg of body weight per day), prednisolone (1 mg/kg per day initially, tapering to 5 to 10 mg per day) and UDCA (500 to 750 mg per day).Clinical and laboratory evaluation, liver biopsy, and endoscopic retrograde cholangiography (a30% change in stenosis was considered significant).After a median observation period of 41 months (ran…

AdultMaleCholagogues and Cholereticsmedicine.medical_specialtyPrednisolonemedicine.medical_treatmentCholangitis SclerosingPilot ProjectsAzathioprineAutoimmune hepatitisGastroenterologyInflammatory bowel diseasePrimary sclerosing cholangitisInternal medicineAzathioprineInternal MedicinemedicineHumansChemotherapybusiness.industryUrsodeoxycholic AcidGeneral Medicinemedicine.diseaseUlcerative colitisUrsodeoxycholic acidSurgeryRadiographyLiverPrednisoloneDrug Therapy CombinationFemalebusinessImmunosuppressive Agentsmedicine.drugAnnals of Internal Medicine
researchProduct

Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies

2001

The aim of this study was to identify the functional cerebral network involved in the central processing of itch and to detect analogies and differences to previously identified cerebral activation patterns triggered by painful noxious stimuli. Repeated positron emission tomography regional cerebral blood flow (rCBF) measurements using O15-labeled water were performed in six healthy right-handed male subjects (mean age 32 +/- 2 years). Each subject underwent 12 sequential rCBF measurements. In all subjects a standardized skin prick test was performed on the right forearm 2 min before each rCBF measurement. For activation, histamine was applied in nine tests in logarithmically increasing con…

AdultMaleCingulate cortexPainPremotor cortexOxygen RadioisotopesmedicineHumansPrefrontal cortexPain MeasurementCerebral CortexTemporal cortexSupplementary motor areaSecondary somatosensory cortexPruritusAnesthesiology and Pain Medicinemedicine.anatomical_structureNeurologyCerebrovascular CirculationNeurology (clinical)Primary motor cortexPsychologyNeuroscienceHistamineTomography Emission-ComputedMotor cortexPain
researchProduct

Concurrent autoimmune diseases in patients with autoimmune hepatitis.

2010

Although the pathomechanisms of autoimmune diseases in various organs remain unresolved, an accumulation of autoimmune diseases in individual patients has been observed. An overlap of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) or primary sclerosing cirrhosis has been well documented. However, the overlap of autoimmune diseases other than PBC or PSC has not yet been investigated in a large cohort.The goal of our analysis was to investigate the incidence of concurrent autoimmune diseases in patients with AIH.We analyzed our cohort of 278 patients with AIH for concurrent autoimmune diseases.A total of 111 patients (40%) were diagnosed with additional autoimmune diseases. Be…

AdultMaleCirrhosisAdolescentAutoimmune hepatitisThyroiditisAutoimmune DiseasesCohort StudiesYoung AdultPrimary biliary cirrhosisImmunopathologyMedicineHumansIn patientChildAgedAutoantibodiesHepatitisAutoimmune diseaseAged 80 and overbusiness.industryLiver Cirrhosis BiliaryGastroenterologyThyroiditis AutoimmuneMiddle Agedmedicine.diseasedigestive system diseasesHepatitis AutoimmuneImmunologyFemalebusinessFollow-Up StudiesJournal of clinical gastroenterology
researchProduct